People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arrogene, Inc | — | Biotechnology | Seed | $7.2M | $23.3M | 2012 |
| Arrogene Nanotechnology Inc | — | Biotechnology | Pre-Seed | $2.1M | $40.1M | 2010 |
| Compumed Inc | — | Other Health Care | Pre-Seed | $120K | $3.7M | 2010 |
MAURIZIO VECCHIONE at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MAURIZIO VECCHIONE on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ROBERT STUCKELMAN | 2 | 2 |
| JULIA LJUBIMOVA | 2 | 2 |
| Jack Kavanaugh | 1 | 6 |
| Mark Crockett | 1 | 4 |
| Robert Snukal | 1 | 3 |
| Marc Rosenberg | 1 | 2 |
| JEFFREY SPERBER | 1 | 2 |
| RANDOLPHE SWENSON | 1 | 1 |
| James A. Hosch | 1 | 1 |
| Larry A. Couture | 1 | 1 |
| Eggehard Holler | 1 | 1 |
| Alexander Ljubimov | 1 | 1 |
| Mark Stolper | 1 | 1 |
| Phuong Dang | 1 | 1 |
| Charles Gillman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.